Jour : 10 novembre 2021

Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

MS Journal, July 9, 2021 https://geneuro.ch/data/news/MSJ-July-21-Efficacy-and-safety-of-temelimab-in-multiple-sclerosis.pdf